BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Renasant Corp
RNST
$3.98B
| $353K | ﹤0.01% |
10,090
+3,483
| +53% | +$119K |
|
2277
Ligand Pharmaceuticals
LGND
$5.83B
| $353K | ﹤0.01% |
5,679
+2,151
| +61% | +$135K |
|
2278
Banner Corp
BANR
$2.51B
| $353K | ﹤0.01% |
6,276
+1,530
| +32% | +$84.4K |
|
2279
CALL
VanEck Oil Services ETF
OIH
$2B
| $353K | ﹤0.01% |
15
-13
| -46% | -$3.37K |
|
|
MDRX
2280
DELISTED
Veradigm Inc. Common Stock
MDRX
| $352K | ﹤0.01% |
32,090
+1,127
| +4% | +$11.6K |
|
2281
Avis
CAR
$4.84B
| $351K | ﹤0.01% |
12,431
-9,634
| -44% | -$295K |
|
2282
La-Z-Boy
LZB
$1.66B
| $351K | ﹤0.01% |
10,455
-563
| -5% | -$18K |
|
2283
PTC Therapeutics
PTCT
$5.94B
| $351K | ﹤0.01% |
10,370
+3,290
| +46% | +$143K |
|
2284
Enphase Energy
ENPH
$5.37B
| $350K | ﹤0.01% |
15,750
+5,528
| +54% | +$142K |
|
2285
CALL
Cognizant
CTSH
$26.5B
| $350K | ﹤0.01% |
58
| – | – |
|
2286
Dine Brands
DIN
$439M
| $349K | ﹤0.01% |
4,594
+142
| +3% | +$11.6K |
|
|
PMT
2287
PennyMac Mortgage Investment
PMT
$832M
| $348K | ﹤0.01% |
15,659
-2,708
| -15% | -$59.7K |
|
2288
Sturm, Ruger & Co
RGR
$599M
| $348K | ﹤0.01% |
8,332
-1,014
| -11% | -$47.4K |
|
2289
CALL
Progressive
PGR
$122B
| $348K | ﹤0.01% |
45
| – | – |
|
|
2290
PUT
Progressive
PGR
$122B
| $348K | ﹤0.01% |
45
| – | – |
|
2291
Horace Mann Educators
HMN
$2.12B
| $348K | ﹤0.01% |
7,502
+1,985
| +36% | +$86.8K |
|
2292
Evertec
EVTC
$1.89B
| $347K | ﹤0.01% |
11,107
+2,345
| +27% | +$78.6K |
|
2293
Ternium
TX
$10.6B
| $346K | ﹤0.01% |
+18,050
| New | +$360K |
|
|
CNH
2294
CNH Industrial
CNH
$16.8B
| $346K | ﹤0.01% |
39,199
+523
| +1% | +$4.6K |
|
|
HI
2295
DELISTED
Hillenbrand
HI
| $346K | ﹤0.01% |
11,208
+919
| +9% | +$29.1K |
|
2296
Walker & Dunlop
WD
$1.47B
| $346K | ﹤0.01% |
6,186
-671
| -10% | -$37.7K |
|
2297
Adient
ADNT
$1.59B
| $345K | ﹤0.01% |
15,041
+10,526
| +233% | +$240K |
|
2298
Simply Good Foods
SMPL
$1B
| $344K | ﹤0.01% |
11,882
+1,352
| +13% | +$37.7K |
|
2299
Aaon
AAON
$7.23B
| $343K | ﹤0.01% |
11,214
+2,413
| +27% | +$77.9K |
|
2300
Cannae Holdings
CNNE
$653M
| $343K | ﹤0.01% |
12,475
-2,553
| -17% | -$72.7K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.